Boyd, Mark A. http://orcid.org/0000-0002-6848-3307
Mocroft, Amanda
Ryom, Lene
Monforte, Antonella d’Arminio http://orcid.org/0000-0003-0073-1789
Sabin, Caroline http://orcid.org/0000-0001-5173-2760
El-Sadr, Wafaa M. http://orcid.org/0000-0003-3735-9781
Hatleberg, Camilla Ingrid
De Wit, Stephane http://orcid.org/0000-0002-8079-6170
Weber, Rainer
Fontas, Eric
Phillips, Andrew http://orcid.org/0000-0003-2384-4807
Bonnet, Fabrice
Reiss, Peter
Lundgren, Jens
Law, Matthew
Funding for this research was provided by:
Danmarks Grundforskningsfond (DNRF126)
National Institute of Allergy and Infectious Diseases (UO1-A1069907)
AbbVie
Bristol-Myers Squibb
Gilead Sciences
ViiV Healthcare
Merck
Janssen Pharmaceuticals
Ministerie van Volksgezondheid, Welzijn en Sport
Agence Nationale de Recherches sur le Sida et les Hepatites Virales
The Foundacton for AIDS Research (amfAR)
Boehringer-Ingelheim
Merck Sharp and Dohme
Janssen-CIlag
Department of Health and Ageing, Australian Government
Fondo de Investigatión Sanitaria (FIS 99/0887)
Fundacion para la investigation y la prevencion del SIDA en España
National Institute of Allergy and Infectious Diseases (5U01AI042170-10)
National Institute of Allergy and Infectious Diseases (5U01AI046362-03)
EuroCoord (260694)
Pfizer
GlaxoSmithKline
The Swiss National Science Foundation (108787)
AbbVie
Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (148522)